Continuum Advisory, LLC Abbott Laboratories Transaction History

Continuum Advisory, LLC

$680 Million
Q2 2024

A detailed history of Continuum Advisory, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Continuum Advisory, LLC holds 10,965 shares of ABT stock, worth $1.23 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

10,965

Previous 10,875 0.83%

Holding current value

$1.23 Million

Previous $1.24 Million 7.85%

% of portfolio

0.17%

Previous 0.19%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	BUY	$100.73 - $112.44 $9,065 - $10,119	90 Added 0.83%	10,965 $1.14 Million
Q1 2024 May 10, 2024	BUY	$109.52 - $120.96 $513,539 - $567,181	4,689 Added 75.8%	10,875 $1.24 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $44,193 - $54,096	-490 Reduced 7.34%	6,186 $680,000
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $8,597 - $10,315	90 Added 1.37%	6,676 $646,000
Q2 2023 Dec 13, 2023	BUY	$100.78 - $112.29 $18,341 - $20,436	182 Added 2.84%	6,586 $718,000
Q2 2023 Aug 10, 2023	BUY	$100.78 - $112.29 $18,341 - $20,436	182 Added 2.84%	6,586 $718,000
Q1 2023 Dec 13, 2023	BUY	$96.86 - $114.01 $16,272 - $19,153	168 Added 2.69%	6,404 $648,000
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $16,272 - $19,153	168 Added 2.69%	6,404 $648,000
Q4 2022 Dec 13, 2023	SELL	$95.06 - $111.52 $22,909 - $26,876	-241 Reduced 3.72%	6,236 $684,000
Q4 2022 Feb 10, 2023	SELL	$95.06 - $111.52 $22,909 - $26,876	-241 Reduced 3.72%	6,236 $684,000
Q3 2022 Dec 13, 2023	BUY	$96.76 - $112.03 $3,096 - $3,584	32 Added 0.5%	6,477 $626,000
Q3 2022 Nov 08, 2022	BUY	$96.76 - $112.03 $3,096 - $3,584	32 Added 0.5%	6,477 $627,000
Q2 2022 Dec 13, 2023	BUY	$102.07 - $123.37 $306 - $370	3 Added 0.05%	6,445 $700,000
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $306 - $370	3 Added 0.05%	6,445 $700,000
Q1 2022 Dec 13, 2023	BUY	$114.02 - $139.04 $91,216 - $111,232	800 Added 14.18%	6,442 $762,000
Q1 2022 May 17, 2022	BUY	$114.02 - $139.04 $91,216 - $111,232	800 Added 14.18%	6,442 $731,000
Q4 2021 Dec 13, 2023	BUY	$115.53 - $141.46 $59,613 - $72,993	516 Added 10.07%	5,642 $794,000
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $59,613 - $72,993	516 Added 10.07%	5,642 $794,000
Q3 2021 Dec 13, 2023	SELL	$116.66 - $129.06 $6,882 - $7,614	-59 Reduced 1.14%	5,126 $605,000
Q3 2021 Nov 08, 2021	SELL	$116.66 - $129.06 $6,882 - $7,614	-59 Reduced 1.14%	5,126 $606,000
Q2 2021 Dec 13, 2023	SELL	$105.79 - $124.53 $157,732 - $185,674	-1,491 Reduced 22.33%	5,185 $601,000
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $62,583 - $73,732	-575 Reduced 9.98%	5,185 $643,000
Q4 2020 May 17, 2021	SELL	$105.0 - $114.42 $1,470 - $1,601	-14 Reduced 0.24%	5,760 $631,000
Q3 2020 May 17, 2021	BUY	$91.64 - $111.29 $529,129 - $642,588	5,774 New	5,774 $627,000

Others Institutions Holding ABT

# of Institutions

3,135

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Continuum Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Continuum Advisory, LLC with notifications on news.

Account

Continuum Advisory, LLC Abbott Laboratories Transaction History